These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 19067498

  • 21. Managed care trends in statin usage.
    Bazalo GR.
    Manag Care; 2001 Oct; 10(10):48-50, 53-9. PubMed ID: 11688111
    [Abstract] [Full Text] [Related]

  • 22. The effect of incentive-based formularies on prescription-drug utilization and spending.
    Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Frank RG.
    N Engl J Med; 2003 Dec 04; 349(23):2224-32. PubMed ID: 14657430
    [Abstract] [Full Text] [Related]

  • 23. Evolutions in both co-payment and generic market share for common medication in the Belgian reference pricing system.
    Fraeyman J, Verbelen M, Hens N, Van Hal G, De Loof H, Beutels P.
    Appl Health Econ Health Policy; 2013 Oct 04; 11(5):543-52. PubMed ID: 24062144
    [Abstract] [Full Text] [Related]

  • 24. Suboptimal statin adherence and discontinuation in primary and secondary prevention populations.
    Ellis JJ, Erickson SR, Stevenson JG, Bernstein SJ, Stiles RA, Fendrick AM.
    J Gen Intern Med; 2004 Jun 04; 19(6):638-45. PubMed ID: 15209602
    [Abstract] [Full Text] [Related]

  • 25. Adherence-adjusted efficacy with intensive versus standard statin therapy in patients with acute myocardial infarction in the IDEAL study.
    Holme I, Szarek M, Cater NB, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Larsen ML, Lindahl C, Pedersen TR, Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group.
    Eur J Cardiovasc Prev Rehabil; 2009 Jun 04; 16(3):315-20. PubMed ID: 19322096
    [Abstract] [Full Text] [Related]

  • 26. Impact of patient and plan design factors on switching to preferred statin therapy.
    Cox ER, Kulkarni A, Henderson R.
    Ann Pharmacother; 2007 Dec 04; 41(12):1946-53. PubMed ID: 17971409
    [Abstract] [Full Text] [Related]

  • 27. Imperative to consider multiple initiatives to maximize prescribing efficiency from generic availability: case history from Abu Dhabi.
    Abuelkhair M, Abdu S, Godman B, Fahmy S, Malmström RE, Gustafsson LL.
    Expert Rev Pharmacoecon Outcomes Res; 2012 Feb 04; 12(1):115-24. PubMed ID: 22280201
    [Abstract] [Full Text] [Related]

  • 28. Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence.
    Balu S, Simko RJ, Quimbo RM, Cziraky MJ.
    Curr Med Res Opin; 2009 Nov 04; 25(11):2765-75. PubMed ID: 19785511
    [Abstract] [Full Text] [Related]

  • 29. Controlling prescription drug expenditures: a report of success.
    Miller DP, Furberg CD, Small RH, Millman FM, Ambrosius WT, Harshbarger JS, Ohl CA.
    Am J Manag Care; 2007 Aug 04; 13(8):473-80. PubMed ID: 17685828
    [Abstract] [Full Text] [Related]

  • 30. Persistence and adherence to cholesterol lowering agents: evidence from Régie de l'Assurance Maladie du Québec data.
    Lachaine J, Rinfret S, Merikle EP, Tarride JE.
    Am Heart J; 2006 Jul 04; 152(1):164-9. PubMed ID: 16824851
    [Abstract] [Full Text] [Related]

  • 31. The effect of a large regional health plan's value-based insurance design program on statin use.
    Frank MB, Fendrick AM, He Y, Zbrozek A, Holtz N, Leung S, Chernew ME.
    Med Care; 2012 Nov 04; 50(11):934-9. PubMed ID: 23047782
    [Abstract] [Full Text] [Related]

  • 32. [Pfizer: TLV decision about antilipemic agents is founded on wrong basis].
    Brun J, Ohlsson-Onerud A, Sörensen N.
    Lakartidningen; 2012 Nov 04; 106(17):1193-4; discussion 1194. PubMed ID: 19530431
    [No Abstract] [Full Text] [Related]

  • 33. What can primary care prescribing data tell us about individual adherence to long-term medication?-comparison to pharmacy dispensing data.
    Mabotuwana T, Warren J, Harrison J, Kenealy T.
    Pharmacoepidemiol Drug Saf; 2009 Oct 04; 18(10):956-64. PubMed ID: 19609958
    [Abstract] [Full Text] [Related]

  • 34. Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization.
    Landsman PB, Yu W, Liu X, Teutsch SM, Berger ML.
    Am J Manag Care; 2005 Oct 04; 11(10):621-8. PubMed ID: 16232003
    [Abstract] [Full Text] [Related]

  • 35. Encouraging generic use can yield significant savings.
    Zimmerman C.
    Find Brief; 2012 Nov 04; 15(8):1-3. PubMed ID: 23213854
    [Abstract] [Full Text] [Related]

  • 36. Drug use evaluation of statins at Siriraj Hospital, 2008.
    Suwansuksree N, Thamlikitkul V, Yamwong P.
    J Med Assoc Thai; 2010 Jan 04; 93 Suppl 1():S179-86. PubMed ID: 20364573
    [Abstract] [Full Text] [Related]

  • 37. Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry.
    O'Brien EC, McCoy LA, Thomas L, Peterson ED, Wang TY.
    Am Heart J; 2015 Jul 04; 170(1):55-61. PubMed ID: 26093864
    [Abstract] [Full Text] [Related]

  • 38. Adherence to lipid-lowering agents among 11,042 patients in clinical practice.
    Wong MC, Jiang JY, Griffiths SM.
    Int J Clin Pract; 2011 Jul 04; 65(7):741-8. PubMed ID: 21676117
    [Abstract] [Full Text] [Related]

  • 39. [Efficacy, safety, and pharmaco-economical aspects of the therapy for dyslipidemia with brand-name and generic statins].
    Ol'binskaia LI, Danilogorskaia IuA.
    Ter Arkh; 2003 Jul 04; 75(12):47-50. PubMed ID: 14959470
    [Abstract] [Full Text] [Related]

  • 40. Adherence and persistence with single-dosage form extended-release niacin/lovastatin compared with statins alone or in combination with extended-release niacin.
    LaFleur J, Thompson CJ, Joish VN, Charland SL, Oderda GM, Brixner DI.
    Ann Pharmacother; 2006 Jul 04; 40(7-8):1274-9. PubMed ID: 16849622
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.